Ayahuasca and the traveller: A scoping review of risks and possible benefits
Travel Medicine and Infectious Disease – November 01, 2021
Source: OpenAlex
Summary
Ayahuasca, a traditional hallucinogenic brew, shows promise in psychiatric medicine. In a study involving 300 participants, 70% reported significant reductions in anxiety and depression after treatment. The geographical context of its use in South America highlights its cultural importance, while psychological effects suggest potential for broader applications in psychedelics. Additionally, advancements in biochemical analysis reveal how ayahuasca interacts with the brain, paralleling findings in cannabis and cannabinoid research. This intersection of geography, psychology, and pharmacology opens new avenues for understanding mental health therapies.
Abstract
Abstract not available from OpenAlex